Table 2.
Proportion of prostate cancer cases by individual Charlson comorbidities
| Charlson comorbidity diseases | Total period
|
Calendar period of registration of comorbidity diseases (%)
|
|||
|---|---|---|---|---|---|
| 2000–2011 | 2000–2002 | 2003–2005 | 2006–2008 | 2009–2011 | |
| Cerebrovascular disease | 717 (9.4) | 106 (8.7) | 165 (9.8) | 232 (10.0) | 214 (8.8) |
| Chronic pulmonary disease | 578 (7.6) | 126 (10.3) | 149 (8.9) | 151 (6.5) | 152 (6.2) |
| Any tumor | 472 (6.2) | 83 (6.8) | 114 (6.8) | 129 (5.6) | 146 (6.0) |
| Myocardial infarction | 472 (6.2) | 73 (6.0) | 108 (6.4) | 131 (5.7) | 160 (6.6) |
| Peripheral vascular disease | 406 (5.3) | 81 (6.6) | 84 (5.0) | 133 (5.7) | 108 (4.4) |
| Congestive heart failure | 378 (4.9) | 82 (6.7) | 95 (5.7) | 106 (4.6) | 95 (3.9) |
| Ulcer disease | 267 (3.5) | 52 (4.3) | 79 (4.7) | 68 (2.9) | 68 (2.8) |
| Diabetes (type I and II) | 251 (3.3) | 47 (3.9) | 55 (3.3) | 71 (3.1) | 78 (3.2) |
| Moderate-to-severe renal disease | 203 (2.7) | 32 (2.6) | 59 (3.5) | 41 (1.8) | 71 (2.9) |
| Diabetes with end organ disease | 179 (2.3) | 41 (3.4) | 31 (1.8) | 44 (1.9) | 63 (2.6) |
| Connective tissue disease | 182 (2.4) | 26 (2.1) | 38 (2.3) | 57 (2.5) | 61 (2.5) |
| Metastatic solid tumor | 51 (0.7) | 3 (0.2) | 9 (0.5) | 15 (0.6) | 24 (1.0) |
| Dementia | 46 (0.6) | 9 (0.7) | 9 (0.5) | 15 (0.6) | 13 (0.5) |
| Mild liver disease | 31 (0.4) | 5 (0.4) | 7 (0.4) | 16 (0.7) | 3 (0.1) |
| Lymphoma | 30 (0.4) | 6 (0.5) | 10 (0.6) | 7 (0.3) | 7 (0.3) |
| Leukemia | 11 (0.1) | 1 (0.1) | 5 (0.3) | 2 (0.1) | 3 (0.1) |
| Hemiplegia | 9 (0.1) | 0 | 1 (0.1) | 2 (0.1) | 6 (0.2) |
| Moderate-to-severe liver disease | 8 (0.1) | 1 (0.1) | 2 (0.1) | 3 (0.1) | 2 (0.1) |
| HIV/AIDS | 2 (0.0) | 0 | 0 | 0 | 2 (0.1) |
Note: Data are presented as n (%).